IL6 and steatosis: Interestingly, the repeated administration of human IL-6 to WT mice causes complete remission of the fatty liver diseases [10, 21, 22] whereas the replacement of IL-6 in IL6-/- mice with fatty liver aggravates the steatosis [12].